Shanghai Fosun Pharmaceutical (Group) Co Ltd 2015 SR
The report highlights Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'s sustainability practices and achievements in 2015. The company continued to focus on pharmaceutical manufacturing and R&D, investing RMB 830 million in research and development. Its subsidiary, Guilin Pharma, made significant contributions to global malaria treatment, with its artesunate series curing nearly 200 million patients. The company also expanded its healthcare services with a RMB 400 million investment in a new hospital in Qingdao. Additionally, Fosun Pharma improved its EHS management system, reducing energy intensity by 8.5% compared to 2014.
Company: Shanghai Fosun Pharmaceutical (Group) Co Ltd
Sector: Manufacturing
Country: China
Year: 2015
Type: SR
Pages: 147
Back to company
Shanghai Fosun Pharmaceutical (Group) Co Ltd
Corporate Social Responsibility Report
The report highlights Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'s sustainability practices and achievements in 2015. The company continued to focus on pharmaceutical manufacturing and R&D, investing RMB 830 million in research and development. Its subsidiary, Guilin Pharma, made significant contributions to global malaria treatment, with its artesunate series curing nearly 200 million patients. The company also expanded its healthcare services with a RMB 400 million investment in a new hospital in Qingdao. Additionally, Fosun Pharma improved its EHS management system, reducing energy intensity by 8.5% compared to 2014.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2015
Reporting Period
Jan 1, 2015 - Dec 31, 2015
Fiscal Year
2015
Type
Sustainability Report
Language
English, Chinese
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Total Waste
Women on Board
Workplace Fatalities
Employees